The Investment Company for Medical Services organized last Tuesday (26 December) in Tripoli, a workshop entitled “Developing Services to Localise Treatment” in cooperation with the Turkey’s Biotechnology Company for Medical and Pharmaceutical Supplies.
Present at the workshop were the Tripoli based Libyan Prime Minister, Abd Alhamid Aldabaiba, the Minister of Economy and Trade, Mohamed Al-Hwej, and the Chairman of the Board of Directors of the National Investment Holding Company, Al-Saghir Maelif.
The external marketing officer of the Turkish Invictus Company, Ibrahim Agababa, and several heads of institutions, agencies, and doctors specialized in the health and medical fields in Libya, also participated.
PPP and international participation in pharmaceutical industry projects
In an exclusive interview with Libya Herald, the Chairman of the National Investment Holding Company, which owns the Investment Company for Medical Services, Al-Saghir Maelif, said that the Investment Holding Company seeks to have a presence in the field of developing and localising medical services and treatment in Libya. It aims to achieve this, he expanded, through direct investment in hospitals and clinics and operating them in partnership with the public sector (PPP), as well as considering the possibility of activating pharmaceutical industry projects in Libya with international participation.
Medical supplies factory designs presented
Maelif stressed that the presence of the Turkish Biotechnology Company for Pharmaceutical Industries is to benefit from the Turkish experience in the pharmaceutical industry, as well as medical equipment and supplies for services. The company included during the workshop a presentation of its medical supplies factory in Kahramanmaras, Turkey, and of designs for a factory to produce medical supplies and packaging that is planned to be established in Misrata.
Two stage agreement to establish medical supplies and medicines
For his part, the Chairman of the Board of Directors of the Investment Company for Medical Services, Bashir Al-Zayani, said that the workshop is being held on the sidelines of an agreement with the Invictus Biotechnology Company in Turkey. This agreement will be to supply a factory for medical supplies and medicines inside Libya. He stressed that the goal of the agreement is to localise treatment inside Libya. It requires the provision of medical and pharmaceutical supplies in this stage and the manufacture of medicine and various medical solutions in the next stage.
Al-Zayani pointed out the readiness of Investment Companies for Medical services to cooperate with local and international companies to localise medical industries in Libya and invest in the health sector. This is in accordance with the investment plan prepared by the National Investment Holding Company, which owns the company, and in cooperation with the health sector, which is trying to localise treatment at home and seek help from international expertise in this field.